In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: CVS Health's current price ($103.69) is significantly below its PERT-weighted fair value ($198.58), implying substantial upside potential. However, poor financial health (1.40/5) and high valuation volatility (CoV 246.23%) indicate elevated investment risk. Monte Carlo analysis shows no downside cases below current price, suggesting limited near-term price erosion.